Novavax Inc on Tuesday delayed the start of a late-stage U.S. trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing ...

The federal guidance comes after many states have already announced their own Covid vaccine recommendations, creating ...

The updated 2025-2026 COVID-19 vaccines are now widely available, but with some new limitations. Who can get the shot this ...

Generic drugmaker Endo said on Friday it was manufacturing Novavax Inc's experimental COVID-19 vaccine, sending its shares up 10% before the trading bell.

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

Novavax (NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid to Sanofi (SNY), in the European ...

GoodRx reports that CDC now recommends COVID-19 vaccinations be decided with healthcare professionals, stressing personalized ...

President Donald Trump has received updated flu and covid-19 booster shots in preparation for upcoming travel, the ...

It's been a confusing and fast-changing couple of months for rules about getting a COVID shot. It should be a little easier ...

Novavax transfers EU rights for Nuvaxovid to Sanofi, earning milestone payments and future royalties. Read more here.

LOS ANGELES (KABC) -- An FDA advisory panel is set to review the data on a potential fourth coronavirus vaccine on Tuesday. Novavax is made with an old school technology, but will it be enough to win ...

The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is protein ...